NYU Langone Medical Center and RTsafe P.C. are collaborating on a research project for the potential dosimetric validation of mask‐based radiosurgery using pseudo‐in‐vivo 3D dosimetry and ion chamber phantoms, developed by RTsafe.
We are pleased to announce that RTsafe is one of the thirteen European high-growth startup companies selected for the European Healthcare Startup Investment Mission to the US organized under the aegis of the U.S. Department of Commerce.
RTsafe is delighted to announce that entrepreneur and angel investor, Marina Hatsopoulos has made an equity investment in RTsafe. Ms Hatsopoulos has experience in both 3D printing and medical technology, both of which are at the core of RTsafe's commercia